Bringing Evidence-Based Digital Therapeutics Directly into Clinical Workflows

A Partnership for Innovation

Resiliency Technologies celebrates an important partnership with EMRAY, an integration platform for health innovators. This collaboration enables seamless embedding into healthcare provider workflows through electronic health record (EHR) pre-integration.

Through this partnership, Resiliency Technologies’ Sharpen DTX solution is now live within healthcare systems that utilize both Epic and Charm Health EHRs. This expansion enhances clinicians’ access to evidence-based treatment interventions. It also paves the way for broader adoption across various clinical settings.

“Clinically proven care only scales when providers can access it without changing how they work. Sharpen DTX eliminates friction at crucial points in the collaborative care process: during primary care visits, while patients are on waitlists for psychiatric care, and for use in between clinical sessions. We are grateful to EMRAY for helping us accelerate impact in all of these areas,” said Robyn Hussa Farrell, CEO and Co-Founder of Resiliency Technologies.

Achieving Clinical Validation

After achieving clinical validation through years of research and collaboration with hundreds of inter-disciplinary researchers in neuroscience, psychology, and resilience, Resiliency Technologies developed a range of evidence-based interventions for diverse conditions. These interventions are united under the digital mental health solution Sharpen DTX.

The company’s next milestone was to bring this digital therapeutic solution into everyday clinical practice. This aims to improve integrated behavioral health best practices. Achieving this required a seamless, clinician-facing interface designed to extend rather than disrupt EHR-based routines. It also needed frictionless connectivity with patient data within the EHR.

Accelerating Clinical Adoption

To accelerate clinical adoption, Resiliency Technologies partnered with EMRAY. This platform is purpose-built for digital health innovators. It features a pre-integrated provider-facing portal and EHR data connectivity capabilities.

Leadership from Resiliency Technologies and EMRAY from left: Bryan Dennstedt, Olga Muller, Robyn Hussa Farrell, Tim Farrell, and Olga Ryzhikova at Charm Health conference 2025.

Adding Resiliency Technologies as an integrated partner on the EMRAY platform allowed rapid traction within hospitals utilizing Epic as their EHR. Separately, Sharpen DTX is also live in Charm Health EHR. In both cases, clinicians can utilize the Sharpen DTX product seamlessly. They can do this without additional logins and windows through single sign-on integration. With very positive early data in hand, Resiliency Technologies is expanding into additional clinic networks. This milestone demonstrates how frictionless EHR integration accelerates the adoption of innovative digital health solutions.

“Resiliency Technologies is exactly the kind of company EMRAY was built for,” said Olga Ryzhikova, CTO of EMRAY. “We make it simple for digital health innovators to implement with healthcare systems faster.”

The Impact of Sharpen DTX

Sharpen DTX is a digital mental health solution by Resiliency Technologies Inc. It delivers scientifically validated digital therapeutic treatment interventions. These interventions are designed to support measurable mental health improvements in children, adolescents, and adults.

Learn more at https://www.sharpenminds.com/dtx.

EMRAY is a platform that accelerates clinical adoption of early healthcare innovations. It does this through quick deployment of EHR-integrated provider-facing portals. Learn more at https://emray.health/.

Future Directions

As the healthcare landscape continues to evolve, the integration of digital therapeutics like Sharpen DTX will become increasingly vital. The collaboration between Resiliency Technologies and EMRAY sets a precedent for future partnerships in the digital health space.

By streamlining access to evidence-based interventions, healthcare providers can offer improved care to their patients. This is especially important in a time when mental health resources are more critical than ever.

The future of healthcare lies in the ability to adapt and innovate. With partnerships like this, the potential for improved patient outcomes is significant.

In conclusion, the integration of digital therapeutics into clinical workflows is not just a trend; it is the future of healthcare. As more providers adopt these solutions, the impact on patient care will be profound.

The journey has just begun, and the possibilities are endless.